We are live on ! Find out more
PHIOW

Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW

Delisted

PHIOW was delisted on the 21st of December, 2021.

Back to rankings

4 hedge funds and large institutions have $84K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less capital invested

Capital invested by funds: $103K → $84K (-$19K)

33% less funds holding

Funds holding: 6 → 4 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$940

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$5K

PHIOW Hedge Fund Activity: Q2 2019 in Review

4 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q2 2019, worth a combined $84K — down 18% from $103K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHIOW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, adding an estimated $940. The largest seller was Sabby Management, exiting entirely with an estimated $5K sold.

  • 4 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q2 2019, down from 6 in Q1 2019.
  • Funds reported $84K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q2 2019, down 18% quarter-over-quarter.
  • 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q2 2019 and 2 closed out, a net change of -2 holders.
  • The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q2 2019 was Susquehanna International Group, an estimated $940 added.
  • The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q2 2019 was Sabby Management, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2019.